319 related articles for article (PubMed ID: 25091475)
1. Detection of increased 64Cu uptake by human copper transporter 1 gene overexpression using PET with 64CuCl2 in human breast cancer xenograft model.
Kim KI; Jang SJ; Park JH; Lee YJ; Lee TS; Woo KS; Park H; Choe JG; An GI; Kang JH
J Nucl Med; 2014 Oct; 55(10):1692-8. PubMed ID: 25091475
[TBL] [Abstract][Full Text] [Related]
2. Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.
Cai H; Wu JS; Muzik O; Hsieh JT; Lee RJ; Peng F
J Nucl Med; 2014 Apr; 55(4):622-8. PubMed ID: 24639459
[TBL] [Abstract][Full Text] [Related]
3. PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.
Luo H; Hong H; Slater MR; Graves SA; Shi S; Yang Y; Nickles RJ; Fan F; Cai W
J Nucl Med; 2015 May; 56(5):758-63. PubMed ID: 25840981
[TBL] [Abstract][Full Text] [Related]
4.
Kwon LY; Scollard DA; Reilly RM
Mol Pharm; 2017 Feb; 14(2):492-501. PubMed ID: 28049295
[TBL] [Abstract][Full Text] [Related]
5. (64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.
Kumar SR; Gallazzi FA; Quinn TP; Deutscher SL
J Nucl Med; 2011 Nov; 52(11):1819-26. PubMed ID: 21984800
[TBL] [Abstract][Full Text] [Related]
6. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.
Holzer AK; Samimi G; Katano K; Naerdemann W; Lin X; Safaei R; Howell SB
Mol Pharmacol; 2004 Oct; 66(4):817-23. PubMed ID: 15229296
[TBL] [Abstract][Full Text] [Related]
7. PET imaging of colorectal and breast cancer by targeting EphB4 receptor with 64Cu-labeled hAb47 and hAb131 antibodies.
Liu S; Li D; Park R; Liu R; Xia Z; Guo J; Krasnoperov V; Gill PS; Li Z; Shan H; Conti PS
J Nucl Med; 2013 Jul; 54(7):1094-100. PubMed ID: 23667241
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.
Holzer AK; Katano K; Klomp LW; Howell SB
Clin Cancer Res; 2004 Oct; 10(19):6744-9. PubMed ID: 15475465
[TBL] [Abstract][Full Text] [Related]
9. High tumor uptake of (64)Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers.
Jørgensen JT; Persson M; Madsen J; Kjær A
Nucl Med Biol; 2013 Apr; 40(3):345-50. PubMed ID: 23394821
[TBL] [Abstract][Full Text] [Related]
10. PET of human prostate cancer xenografts in mice with increased uptake of 64CuCl2.
Peng F; Lu X; Janisse J; Muzik O; Shields AF
J Nucl Med; 2006 Oct; 47(10):1649-52. PubMed ID: 17015901
[TBL] [Abstract][Full Text] [Related]
11. PET imaging of EGFR expression in nude mice bearing MDA-MB-468, a human breast adenocarcinoma.
Sadri K; Ren Q; Zhang K; Paudyal B; Devadhas D; Rodeck U; Thakur M
Nucl Med Commun; 2011 Jul; 32(7):563-9. PubMed ID: 21572364
[TBL] [Abstract][Full Text] [Related]
12. Theranostics of malignant melanoma with 64CuCl2.
Qin C; Liu H; Chen K; Hu X; Ma X; Lan X; Zhang Y; Cheng Z
J Nucl Med; 2014 May; 55(5):812-7. PubMed ID: 24627435
[TBL] [Abstract][Full Text] [Related]
13. Pilot Study of
Jiang L; Tu Y; Hu X; Bao A; Chen H; Ma X; Doyle T; Shi H; Cheng Z
Sci Rep; 2017 May; 7(1):2574. PubMed ID: 28566692
[TBL] [Abstract][Full Text] [Related]
14. Preclinical PET imaging study of lung cancer with
Wang Q; Song D; Ma X; Wu X; Jiang L
Ann Nucl Med; 2020 Sep; 34(9):653-662. PubMed ID: 32567008
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
[TBL] [Abstract][Full Text] [Related]
16. Iron, copper, and zinc transport: inhibition of divalent metal transporter 1 (DMT1) and human copper transporter 1 (hCTR1) by shRNA.
Espinoza A; Le Blanc S; Olivares M; Pizarro F; Ruz M; Arredondo M
Biol Trace Elem Res; 2012 May; 146(2):281-6. PubMed ID: 22068728
[TBL] [Abstract][Full Text] [Related]
17. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1).
Du X; Wang X; Li H; Sun H
Metallomics; 2012 Jul; 4(7):679-85. PubMed ID: 22552365
[TBL] [Abstract][Full Text] [Related]
18. PET imaging analysis with 64Cu in disulfiram treatment for aberrant copper biodistribution in Menkes disease mouse model.
Nomura S; Nozaki S; Hamazaki T; Takeda T; Ninomiya E; Kudo S; Hayashinaka E; Wada Y; Hiroki T; Fujisawa C; Kodama H; Shintaku H; Watanabe Y
J Nucl Med; 2014 May; 55(5):845-51. PubMed ID: 24627433
[TBL] [Abstract][Full Text] [Related]
19. Stable plasma membrane levels of hCTR1 mediate cellular copper uptake.
Eisses JF; Chi Y; Kaplan JH
J Biol Chem; 2005 Mar; 280(10):9635-9. PubMed ID: 15634665
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin.
Liang ZD; Stockton D; Savaraj N; Tien Kuo M
Mol Pharmacol; 2009 Oct; 76(4):843-53. PubMed ID: 19570948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
